Premium
THE SUSCEPTIBILITY OF CANDIDA ALBICANS TO AMPHOTERICIN B, NYSTATIN, AND 5‐FLUOROCYTOSINE
Author(s) -
Hamra Laurence Kameel,
Pankiewicz Irene J.
Publication year - 1977
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1977.tb99257.x
Subject(s) - nystatin , amphotericin b , candida albicans , microbiology and biotechnology , flucytosine , corpus albicans , antibiotics , medicine , antifungal , biology
Sensitivity tests were performed on 332 consecutive isolates of Candida albicans. All isolates were inhibited by 0·5 μg/ml of amphotericin B, and 6·4 μ/ml of nystatin; and 92·5% of strains were inhibited by 25 μg/ml of 5‐fluorocytosine. Therefore, all three drugs may be employed clinically in the treatment of candidiasis with a reasonable chance of success.